Sarcosine → HCID 59604108, compound

HRID 219581Notes

Reaction equation

HRID 219581 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[N:8]1[C:12]([C:13]2[CH:18]=[CH:17][N:16]=[CH:15][CH:14]=2)=[C:11]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:31]=[CH:30][C:27]([CH:28]=O)=[CH:26][CH:25]=3)[N:20]=2)[N:10]=[N:9]1.[CH3:32][NH:33][CH2:34][C:35]([OH:37])=[O:36]>>[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[N:8]1[C:12]([C:13]2[CH:18]=[CH:17][N:16]=[CH:15][CH:14]=2)=[C:11]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:31]=[CH:30][C:27]([CH2:28][N:33]([CH3:32])[CH2:34][C:35]([OH:37])=[O:36])=[CH:26][CH:25]=3)[N:20]=2)[N:10]=[N:9]1

Participants

3

Reactant 2

HCID 1088SarcosineHCID 866481594-(5-(1-(2-fluorophenyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-3-yl) benzaldehyde

Product 1

HCID 59604108HCID 59604108, compound

Procedure

The title compound was prepared following the procedure described for Example 94, but starting from 4-(5-(1-(2-fluorophenyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-3-yl)benzaldehyde, obtained as described in Example 113, Step 1, (100 mg; 0.24 mmol) and 2-(methylamino)acetic acid (43.2 mg; 0.48 mmol) to give Example 130 as a white solid. 1H NMR: (DMSO-d6, 400 MHz) δ 8.76-8.73 (2H, m), 7.97 (2H, d, J=8.0 Hz), 7.93-7.88 (1H, m), 7.76-7.69 (1H, m), 7.63-7.58 (2H, m), 7.61-7.47 (4H, m), 3.78 (2H, s), 3.26 (2H, s), 2.32 (3H, s). LC/MS (Method C): 484 (M+H)+. HPLC (Method E) Rt 2.36 min (Purity: 98.9%).

Workup

  1. customobtained

Sources & evidence

ORD record
ord-fbd91b8f8d1444538cd455cdeb651d5c
Source dataset
uspto-grants-2012_06
Patent number
US08202856B2

Reaction notes

Loading…